Congressional Amendment Targets VA Medical Cannabis Policy
Bipartisan congressional lawmakers have introduced an amendment designed to permit Department of Veterans Affairs (VA) doctors to provide medical cannabis recommendations to military veterans. The proposal, put forth by Representatives Brian Mast (R-FL), Dave Joyce (R-OH), and Dina Titus (D-NV), seeks to modify a long-standing VA directive that currently restricts its healthcare providers from assisting veterans in registering for state-approved medical cannabis programs.
Under the existing Veterans Health Directive 1315, VA medical professionals are permitted to discuss marijuana use with their patients. However, they are prohibited from completing the necessary forms or officially registering veterans for participation in state medical cannabis programs. This policy necessitates that veterans seek external services from non-VA providers to obtain legal access to medical cannabis, rather than receiving assistance from their primary VA doctors.
Proposed Changes to Veterans Health Directive 1315
The amendment, offered to the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, directly addresses the limitations imposed by Veterans Health Directive 1315. If enacted, it would prevent the VA from enforcing specific provisions of the directive, including:
- The policy stating that “VHA providers are prohibited from completing forms or registering Veterans for participation in a State-approved marijuana program.”
- The directive for the “Deputy Under Secretary for Health for Health for Operations and Management” to ensure that “medical facility Directors are aware that it is VHA policy for providers to assess Veteran use of marijuana but providers are prohibited from recommending, making referrals to or completing paperwork for Veteran participation in State marijuana programs.”
- The directive for the “VA Medical Facility Director” to ensure that “VA facility staff are aware of the following” “[t]he prohibition on recommending, making referrals to or completing forms and registering Veterans for participation in State-approved marijuana programs.”
The House Rules Committee is expected to review submitted amendments, including this one, to determine which will proceed to floor votes.
Legislative Context and Related Developments
This is not the first attempt to address medical cannabis access for veterans through federal legislation. Similar proposals have previously passed both the House of Representatives and the Senate in past years but have not been enacted into law. The current amendment follows the recent federal rescheduling of medical marijuana by the Trump administration, a development that advocates believe could improve the prospects for this veterans-focused reform to be enacted this year, as reported by Marijuana Moment.
Beyond medical cannabis, other legislative efforts in Congress are also addressing veteran healthcare. A separate amendment to the military and veterans spending bill, introduced by Representatives Lou Correa (D-CA) and Jack Bergman (R-MI), aims to increase funding for the Medical and Prosthetic Research account at the Department of Veterans Affairs. This amendment seeks to emphasize the department’s research into areas benefiting veterans, including oncology, traumatic brain injury care, psychedelic therapies, and assistive devices.
Concurrently, other legislative actions are underway. The House Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies recently approved a bill containing provisions that would block federal officials from taking further steps to reschedule cannabis. Separately, the House Appropriations Committee approved a spending bill and an attached report expressing concerns about health risks from cannabis-derived products, while also encouraging research into the potential benefits of psychedelics. Additionally, the full House passed a Farm Bill with provisions aimed at aiding industrial hemp producers, though it did not include language to delay or alter the federal recriminalization of hemp THC products scheduled to take effect later this year.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
